Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: A randomized, placebo-controlled, double-blind study

Human Reproduction

Volumn 25, Issue 12, 2010, Pages 2972-2977

  Haapsamo, Mervi ^a   Martikainen, Hannu ^a   Tinkanen, Helena ^b   Heinonen, Seppo ^c   Nuojua Huttunen, Sinikka ^d   Räsänen, Juha ^a,e  

^a UNIVERSITY OF OULU   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d Infertility Clinic   (Finland)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

antiplatelet therapy; assisted reproduction; intrauterine growth restriction; pre eclampsia; pregnancy induced hypertension

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; OVARY HYPERSTIMULATION; PREECLAMPSIA; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 78649505882     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq286     Document Type: Article

References (33)

1. ACOG (2002) ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;77:67-75.
2. Allen VM, Wilson RD, Cheung A. Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can 2006;28:220-250.
3. Askie LM, Duley H, Henderson-Smart DJ, Stewart LA, PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369:1791-1798.
4. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1:177-191.
5. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:619-629.
6. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007;18:CD004659.
7. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130-137.
8. Ebrashy A, Ibrahim M, Marzook A, Yousef D. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial. Croat Med J 2005;46:826-831.
9. ECPPA Collaborative Group. ECPPA: randomized trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. BJOG 1996;103:39-47.
10. Giles WB, Trudinger BJ, Baird PJ. Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation. Br J Obstet Gynaecol 1985;92:31-38.
11. Haapsamo M, Martikainen H, Räsänen J. Low-dose aspirin reduces uteroplacental vascular impedance in early and mid gestation in IVF and ICSI patients: a randomized, placebo-controlled double-blind study. Ultrasound Obstet Gynecol 2008;32:687-693.
12. Haapsamo M, Martikainen H, Räsänen J. Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF/ICSI-a randomized, placebo-controlled double-blind study. Hum Reprod 2009;24:861-866.
13. Epub 2009 January 18. Harrington K, Kurdi W, Aquilina J, England P, Campbell S. A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks. Ultrasound Obstet Gynecol 2000;15:13-18.
14. Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004;103:551-563.
15. Källen B, Finnström O, Nygren KG, Otterblad Olausson P, Wennerholm UB. In vitro fertilisation in Sweden: obstetric characteristics, maternal morbidity and mortality. BJOG 2005;112:1529-1535.
16. Koivurova S, Hartikainen AL, Karinen L, Gissler M, Hemminki E, Martikainen H, Tuomivaara L, Järvelin MR. The course of pregnancy and delivery and the use of maternal healthcare services after standard IVF in Northern Finland 1990-1995. Hum Reprod 2002; 17:2897-2903.
17. Lambers M, Groenenveld E, Hoozemans D, Schats R, Homburg R, Lambalk C, Hompes P. Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. Hum Reprod 2009a;24:2447-2450.
18. Lambers MJ, Hoozemans DA, Schats R, Homburg R, Lambalk CB, Hompes PG. Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial. Fertil Steril 2009b;92:923-929.
19. Epub 2008 October 29. Maman E, Lunenfeld E, Levy A, Vardi H, Potashnik G. Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously. Fertil Steril 1998;70:240-245.
20. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. BJOG 1994; 101:669-764.
21. Päkkilä M, Räsänen J, Heinonen S, Tinkanen H, Tuomivaara L, Mäkikallio K, Hippeläinen M, Tapanainen JS, Martikainen H. Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study. Hum Reprod 2005;20:2211-2214.
22. Pihkala J, Hakala T, Voutilainen P, Raivio K. Characteristic of recent fetal growth curves in Finland. Duodecim 1989;105:1540-1546.
23. Rotchell YE, Cruickshank JK, Gay MP, Griffiths J, Stewart A, Farrell B, Ayers S, Hennis A, Grant A, Duley L et al. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomized trial for the prevention of pre-eclampsia and its complications. BJOG 1998; 105:286-292.
24. Shevell T, Malone FD, Vidaver J, Porter TF, Luthy DA, Comstock CH, Hankins GD, Eddleman K, Dolan S, Dugoff L et al. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol 2005;106:1039-1045.
25. Tarim E, Bal N, Kilicdag E, Kayaselcuk F, Bag?iş T, Kuscu E. Effects of aspirin on placenta and perinatal outcomes in patients with poor obstetric history. Arch Gynecol Obstet 2006;274:209-214.
26. Tulppala M, Marttunen M, Söderstrom-Anttila V, Foudila T, Ailus K, Palosuo T, Ylikorkala O. Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Hum Reprod 1997;12:1567-1572.
27. Vainio M, Kujansuu E, Iso-Mustajärvi M, Mäenpää J. Low dose acetylsalisylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002;109:161-167.
28. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232-235.
29. Wada I, Hsu CC, Williams G, Macnamee MC, Brinsden PR. The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Hum Reprod 1994;9:1954-1957.
30. Walsh SW. Pre-eclampsia: an imbalance in placental prostacycline and thromboxane production. Am J Obstet Gynecol 1985;152: 335-340.
31. Wang Y, Walsh SW, Kay HH. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with pre-eclampsia. Am J Obstet Gynecol 1992;167:946-949.
32. Weckstein LN, Jacobson A, Galen D, Hampton K, Hammel J. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertil Steril 1997; 68:927-930.
33. Willis AL. An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin. Science 1974;183:325-327.